Introduction
The outlook for patients with Cushing's syndrome due to non-malignant adrenal disease has improved greatly in the last 30 years following the introduction of a variety of procedures aimed at reduction of the excessive cortisol production.
Pituitary irradiation alone controlled hypercortisolaemia satisfactorily in less than half (Soffer et al., 1955; Orth & Liddle, 1971; Scott et al., 1977) but the advent of bilateral adrenalectomy and, more recently, of pituitary microsurgery has ensured that hypercortisolaemia can be controlled in nearly all cases (Cope & Raker, 1955; Ernest & Ekman, 1972; KasperlikZaluska et al., 1978; Hardy, 1969; Urbanic & George, 1981) .
It is the purpose of this paper to emphasize that normalization ofcortisol production is not necessarily followed by remission of the clinical features and that there is a continuing high morbidity and excessive mortality from the disease, largely due to persistence of the cardiovascular manifestations.
Patients
Fifty-seven patients above the age of 16 y who had biochemically proven Cushing's syndrome due to nonmalignant disease have been treated at University College Hospital and personally followed-up for a period extending over 30 y. The diagnostic criteria of many of the earlier cases were reviewed in 1966 by Ross, Marshall-Jones and Friedman at a time when methods ofdiagnosis were not as precise as is currently possible and any equivocal cases from that series have been excluded in the present survey. These patients and later cases have all had sustained hypercortisolaemia, with loss of diurnal variation, increased urinary excretion ofcortisol and resistance to suppression with dexamethasone.
Histological confirmation was obtained operatively in those who underwent adrenalectomy or pituitary microsurgery, but not in those treated by pituitary irradiation or drug therapy. There were 8 cases of adrenal adenoma and 49 cases with adrenocortical hyperplasia. Forty-nine ofthe 57 patients were female. No cases of adrenocortical carcinoma, the ectopic ACTH syndrome, or alcohol-dependent hypercortisolaemia have been included.
Extensive search within the abdominal cavity failed to reveal ectopic adrenal tissue but post-operatively all the biochemical and clinical features of Cushing's syndrome resolved, presumably due to infarction during surgery of an adenoma in an adrenal rest.
Adrenocortical hyperplasia
Forty-nine patients with adrenal hyperplasia have received treatment (Table I) . Pituitary irradiation with 38-4OGs (3800-4000r) was used to treat 23 patients. One of these patients required a second course of 40Gs because of continuing hypercortisolaemia. A further 5 patients who did not have an acceptable biochemical response received bilateral adrenalectomy at a later date. Total bilateral adrenalectomy was used as the sole treatment in 16 patients. In the early part of this series an intended subtotal adrenalectomy was performed in 5 cases; and in a further patient following an inadequate response to pituitary irradiation. In 2 of these 6 patients the adrenalectomy was effectively complete since the patients were never able to come off replacement therapy and showed no adrenal response to stimulation by corticotrophin.
Results

Biochemical response to treatment
All patients treated by bilateral adrenalectomy required long-term cortisol replacement therapy using hydrocortisone indicating the efficacy of the total adrenalectomy. The dose was adjusted to the lowest amount consistent with clinical well-being and satisfactory plasma cortisol concentration. The usual Table II ) must necessarily be subjective and has been assigned to one of four categories on the basis of the degree ofremission ofhypertension, diabetes, obesity, menstrual and psychological derangement, hirsutism, myopathy and ability to resume their previous occupa- minimal improvement only in all signs and symptoms or failure of at least 3 features of the disease to remit. This category also includes deaths in the perioperative period.
Adrenocortical adenoma
Four out of 8 patients had a good response and 4 had only a fair or poor response, one of the latter being a postoperative death. Seven of these patients had hypertension and this remitted completely in only one patient.
Bilateral adrenal hyperplasia: Pituitary irradiation
There was only one complete remission in the 23 patients so treated. Nine patients had a good clinical response, although one of these relapsed 2 years later and required bilateral adrenalectomy. Five patients had a fair response but 9 patients responded poorly. The five patients who subsequently required bilateral adrenalectomy because of persistent hypercortisolaemia all had a poor clinical response.
Bilateral adrenalectomy
Twenty-two patients were treated by bilateral adrenalectomy (although 2 were intended to be only subtotal). Three of these patients died within 6 months. One death was in the early postoperative period; the cause for this was not established. Another died 2 months after surgery from a cerebrovascular accident and bronchopneumonia; there had been a poor clinical response to adrenalectomy up to the time ofdeath. The third death 6 months postoperatively occurred in a patient who had shown a good clinical response to treatment and was due to a viral disease complicated by acute adrenal insufficiency. In the other 17 patients response was excellent in 2, good in 8, fair in 5 and poor in 2.
Subtotal adrenalectomy
Four patients were subtotally adrenalectomized. The clinical response was excellent in 1, good in 2 and poor in 1. Despite these satisfactory results this method of treatment was soon abandoned because of the high incidence of relapse reported from other centres.
Drug treatment
All 4 patients responded poorly, both biochemically and clinically and have now been treated by bilateral adrenalectomy (1 case) or pituitary microsurgery.
Pituitary microsurgery
The clinical response of the 5 patients cannot yet be fully assessed as follow-up is short and they are not therefore included in Table II Fifty ofthe remaining patients in this study survived beyond the 1st year of their definitive treatment and have been followed over a period of up to 30 y. No deaths have occurred among the 4 males. Forty-six female patients have a total follow-up period of 531 y which allows statistical analysis ofthe late mortality to be performed. The number of deaths expected in a general population during this period has been estimated from the sum of the yearly crude mortality rates at the year of entry to the series, and the age and sex of the patient. The expected number ofdeaths was 4, compared with the actual number in the series of 16. The percentage mortality in the series compared with a matched general population over a corresponding 20 y period is compared in the figure. It should be noted that the excess mortality occurred mainly in the first 5 y after treatment. Thirteen of the 16 deaths were due to cardiovascular disease (81%) (see Table IV ). One death was due to suicide 2 y after removal of an adrenal adenoma in a seriously disturbed patient, one was due to pulmonary embolism 20 y after adrenalectomy. The remaining patient died in another hospital and no cause was found at autopsy. 
Discusion
Treatment by pituitary irradiation resulted in biochemical remission in 69% of our patients but a prolonged clinical remission occurred in only 50% of those with normalized cortisol secretion. This is in agreement with the results of Dohan et al. (1957) ; Soffer et al. (1961) ; Orth & Liddle (1971) and Scott et al. (1977) . This form of treatment when successful, also had the disadvantage of slow resolution of the clinical features of the disease, but has the advantage of non-dependence on subsequent replacement therapy. Although bilateral adrenalectomy had the advantage of curing hypercortisolaemia in virtually all patients, there was a significant mortality within the first year of 8% including a perioperative mortality of 3.8%. An early mortality of up to 25% appears in various published series (Sprague et al., 1961; Welbourn et al., 1971; Ernest & Ekman, 1972; Scott et al., 1977; Urbanic & George, 1981; Tomita et al., 1981; Skalkeas et al., 1982 , Pelkonen et al., 1983 . This perioperative mortality can now be minimized by preoperative preparation with metyrapone or other inhibitors of cortisol synthesis, together with advances in surgical and anaesthetic techniques including antibiotics. The disadvantages of this form of treatment, apart from the operative mortality and morbidity, include life-long hydrocortisone replacement therapy and constant vigilance on the part of the patient to recognize situations requiring adjustment of replacement therapy. Enlargement ofa pituitary adenoma following adrenalectomy occurred in only one of our patients (4.2%), but the prevalence of this complication is often higher in other series (Kelly et al., 1983) .
Adrenalectomy has been largely displaced by pituitary adenomectomy in patients with pituitarydependent hypercortisolaemia (Hardy, 1969) . A recent report by Boggan et al. (1983) claims correction of hypercortisolaemia in 78 of 100 patients with subsequent relapse in four. Sixty-two patients are stated to have had long term remission but no analysis of clinical response is given. In our limited experience this procedure succeeds in reducing cortisol secretion within one or two days, necessitating glucocorticoid replacement therapy for varying periods up to 9 months when endogenous secretion recovers. All our patients treated by pituitary microsurgery suffered severe post-operative depression with constant complaints of weakness, muscle pain, tiredness and loss of energy; they were reluctant to return to work or resume their household activity for several months, when this post-operative malaise abruptly remitted. Three ofour 5 patients so far have had a good response to treatment, in accordance with the reports of other small series, although results are very variable (Burch, 1983) .
Patients with adrenocortical adenoma responded to treatment by resection in a similar manner to those with bilateral hyperplasia, a successful clinical response being achieved in 54% of those with bilateral hyperplasia and 50% of those with adrenal adenoma. One of the adenoma patients died from cerebrovascular disease and one committed suicide 2y postoperatively. The series published by Valimaki et al. (1984) , also contained 1 postoperative suicide among 14 patients. The serious psychological involvement of patients with adrenal adenoma and hence suppressed pituitary secretion of corticotrophin throws doubt on the views of Starkman and Schteingart (1981) concerning the role of corticotrophin in the cause of the mental depression so common in this disease.
When treament results in successful control of hypercortisolaemia, it might be expected that clinical remission would follow. Although 'cure' is often claimed, detailed clinical information is frequently lacking. Complete remission of all manifestations of the disease in our experience occurs in a minority of patients, less than 10% in our series. Resolution of all but one feature occurred in 48%. Important manifestations which failed to resolve were hypertension, carbohydrate intolerance and obesity.
Hypertension persisted in 70% of our patients, although usually to a less severe degree. In their informative rport of the results of adrenalectomy Ernest and Ekman (1972) noted that 14 of their 21 patients remained hypertensive. Welbourn et al. (1970) and Urbanic and George (1981) report persistence of hypertension in about one third of their patients.
Impaired glucose tolerance present pre-operatively in 18 of our patients remitted completely in 67% and partially in 11%. In 17 of those patients it coexisted with hypertension. Welbourn et al. (1971) noted that all their mildly diabetic patients became normoglycaemic after adrenalectomy, as did one of two severely diabetic patients.
Obesity responds poorly to definitive treatment of Cushing's syndrome, about 50% remaining obese. Although some may lose weight within the first year or two after treatment, most regain this weight with prolonged follow-up. This accords with the observation ofErnest and Ekman (1972) who found that only l2oftheir25 patientson prolonged follow-up had lost weight, and of Urbanic and George (1981) in whose series 42% remained obese. Although failure to lose weight is often regarded (by the doctor, not the patient) as ofminor importance, it is a recognized risk factor aggravating cardiovascular disease.
Review of this series of patients with hypercortisolaemia and the reports of others have emphasized that this is still a potentially lethal disease, the mortality in our patients being 4 times that of a similar general population matched for age, sex and year of entry. Cardiovascular disease accounted for 81 % of the deaths in this series, death occurring mainly in the first 5 y following definitive treatment. Hypertension at time of diagnosis was a serious obstacle to prolonged survival. Twelve of the 30 patients who remained hypertensive after treatment subsequently died of cerebrovascular disease (9 patients), congestive heart failure (2), myocardial infarction (1) and pulmonary embolism (1). These mortality figures underline the severe hypertension which may dominate the clinical picture and persist despite correction of hypercortisolaemia and vigorous treatment with antihypertensive agents. Welbourn et al. (1972) reported that cardiovascular disease was the major cause of death with the first year following adrenalectomy, 5 of their 25 patients dying from this complication. During subsequent follow-up 7 of 10 deaths in their 41 patients were cardiovascular in causation. Similar emphasis on the high proportion of deaths due to cardiovascular disease has been made by Sprague et al. (1961) , Ernest and Ekman (1972) and Valimaki et al. (1984) .
The 5 y survival in this series of 77% is certainly an improvement on the outcome in untreated patients where the 5 y survival is approximately 50% (Plotz et al., 1952; Sprague et al., 1961) .
The frequent poor clinical response to treatment and the high mortality from cardiovascular complications in this disease is, however, disturbing. The average duration of symptoms before diagnosis in this series was 5 y. It is hoped that earlier diagnostic consideration of the possibility of hypercortisolaemia will result in speedier treatment before irreparable vascular damage has occurred. Restoration to normal cortisol secretion by the various forms of treatment currently available is easy. To produce a lasting clinical remission is more difficult.
